Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin [Original Articles]
Conclusions—
Patients who initiated dabigatran treatment were more persistent than patients who began warfarin treatment. Within each cohort, patients with lower stroke risk were more likely to discontinue therapy.
Source: Circulation: Cardiovascular Quality and Outcomes - Category: Cardiology Authors: Zalesak, M., Siu, K., Francis, K., Yu, C., Alvrtsyan, H., Rao, Y., Walker, D., Sander, S., Miyasato, G., Matchar, D., Sanchez, H. Tags: Compliance/Adherence, Other anticoagulants, Arrhythmias, clinical electrophysiology, drugs, Anticoagulants Original Articles Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Cardiovascular | Coumadin | Heart | Pradaxa | Stroke | Study | Warfarin